Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,476,005
  • Shares Outstanding, K 35,930
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,610 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.79
Trade CMPS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 114.75%
  • Historical Volatility 105.63%
  • IV Percentile 25%
  • IV Rank 9.05%
  • IV High 314.68% on 12/18/20
  • IV Low 94.86% on 11/24/20
  • Put/Call Vol Ratio 0.61
  • Today's Volume 388
  • Volume Avg (30-Day) 1,018
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 6,280
  • Open Int (30-Day) 7,521

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.36
  • Number of Estimates 1
  • High Estimate -0.36
  • Low Estimate -0.36
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.61 +22.23%
on 03/05/21
58.62 -29.92%
on 02/22/21
-4.17 (-9.22%)
since 02/05/21
3-Month
33.61 +22.23%
on 03/05/21
61.69 -33.41%
on 12/14/20
-7.92 (-16.16%)
since 12/04/20

Most Recent Stories

More News
Global Behavioral Health Market Where Psychedelics Have Shown Tremendous Potential Could Hit $240 Billion By 2026

, /PRNewswire/ -- Many people and investors may be confused, thinking that the Psychedelics market is part of the cannabis market. It is not a way to get higher 'highs' in the legal cannabis market…...

MCUR.CN : 0.485 (+1.04%)
CLXPF : 1.1495 (-3.62%)
MCURF : 0.3900 (+0.31%)
CMPS : 41.08 (+3.71%)
FTRP.CN : 6.480 (unch)
FTRPF : 5.1876 (+0.55%)
RVV.CN : 0.370 (-3.90%)
RVVTF : 0.3046 (-0.23%)
PHRM.CN : 0.235 (-7.84%)
PHRRF : 0.1855 (-7.80%)
Ketamine Could Potentially Increase Life Expectancy for Lou Gehrig’s Disease Patients

Psychedelics, like ketamine could be a game-changer for the medical community. In addition to psilocybin, ...

MMEDF : 2.8600 (-3.05%)
CMPS : 41.08 (+3.71%)
MYCOF : 0.3062 (+0.86%)
PSYC.CN : 0.350 (-5.41%)
PSYCF : 0.2827 (-3.75%)
PHRRF : 0.1855 (-7.80%)
MYCO.CN : 0.390 (-2.50%)
PHRM.CN : 0.235 (-7.84%)
First Movers in the Psychedelics Space Position Themselves as Industry Leaders

, /PRNewswire/ -- The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have seen in decades. Far from being...

PULL.CN : 0.495 (-4.81%)
PRXTF : 0.4000 (unch)
RVV.CN : 0.370 (-3.90%)
RVVTF : 0.3046 (-0.23%)
MYCO.CN : 0.390 (-2.50%)
MYCOF : 0.3062 (+0.86%)
AIKI : 1.0600 (+4.95%)
CMPS : 41.08 (+3.71%)
Forget Cannabis - Psilocybin May be the Next Big Opportunity

Psilocybin is becoming one of the hottest buzzwords of the year. Major studies are already showing ...

MMEDF : 2.8600 (-3.05%)
CMPS : 41.08 (+3.71%)
CLXPF : 1.1495 (-3.62%)
SEEL : 2.60 (-2.26%)
NMDBF : 0.2153 (-0.32%)
NEON.CN : 0.260 (-3.70%)
Could the Federal Government Help Legalize Psychedelics?

Psychedelics are going mainstream. Not only is the US FDA supportive of research, dozens of medical ...

CLXPF : 1.1495 (-3.62%)
MMEDF : 2.8600 (-3.05%)
CMPS : 41.08 (+3.71%)
MCURF : 0.3900 (+0.31%)
NUMI.VN : 1.280 (-1.54%)
LKYSF : 1.0199 (-0.98%)
MCUR.CN : 0.485 (+1.04%)
Psilocybin Extracts Could Be the Key to Unlocking Psychedelic Health and Wellness

, /PRNewswire/ -- Psychedelics have made some spectacular breakthroughs to gain legitimacy as mental healthcare products and to become an emerging health and wellness market of its own. As these products...

PULL.CN : 0.495 (-4.81%)
PRXTF : 0.4000 (unch)
CMPS : 41.08 (+3.71%)
CLXPF : 1.1495 (-3.62%)
AIKI : 1.0600 (+4.95%)
NUMI.VN : 1.280 (-1.54%)
LKYSF : 1.0199 (-0.98%)
Psilocybin Could be a Major Game Changer for Millions of People

The psychedelics story is quickly gaining momentum. Over the last few months, Denver, Oakland, and ...

MMEDF : 2.8600 (-3.05%)
NUMI.VN : 1.280 (-1.54%)
LKYSF : 1.0199 (-0.98%)
CMPS : 41.08 (+3.71%)
CLXPF : 1.1495 (-3.62%)
PSYG.CN : 0.360 (+1.41%)
Psychedelic Treatments Providing Hope for the Mental Health Pandemic

The thought of tribulations endured as the world celebrates this year end are uncanny, with unanimous ...

CMPS : 41.08 (+3.71%)
DRUG.CN : 6.950 (-3.74%)
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists

CMPS : 41.08 (+3.71%)
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy

COMPASS Pathways announces publication in Frontiers in Psychiatry

CMPS : 41.08 (+3.71%)

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 53.36
2nd Resistance Point 47.91
1st Resistance Point 44.50
Last Price 41.08
1st Support Level 35.64
2nd Support Level 30.19
3rd Support Level 26.78

See More

52-Week High 61.69
Fibonacci 61.8% 46.72
Fibonacci 50% 42.10
Last Price 41.08
Fibonacci 38.2% 37.48
52-Week Low 22.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar